id | Study | Lib. in paper | Exposition period | Study type |
Control type |
Tags | OR 95%CI | x1/n1 x0/n0 | no cases | no exposed | ROB | Ref. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S4098 R8748 |
Carman - Etanercept (Controls unexposed, disease free), 2017 | Central nervous system | during pregnancy (anytime or not specified) | retrospective cohort (claims database) | unexposed, disease free excluded | Adjustment: No |
1.03 [0.05;21.46] C excluded (control group) |
0/210 2/1,078 | 2 | 210 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4099 R8763 |
Carman - Etanercept (Controls unexposed, sick), 2017 | Central nervous system | during pregnancy (anytime or not specified) excluded | retrospective cohort (claims database) | unexposed, sick | Adjustment: No |
1.84 [0.09;38.50] C excluded (exposition period) |
0/210 2/1,932 | 2 | 210 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3194 R5157 |
Bröms a (Controls unexposed, disease free), 2016 | Nervous system | 3 months or more before pregnancy or1st trimester | population based cohort retrospective | unexposed, disease free excluded | Adjustment: No |
1.08 [0.15;7.66] C excluded (control group) |
1/683 1,699/1,250,192 | 1,700 | 683 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S3193 R5135 |
Bröms a (Controls unexposed, sick), 2016 | Nervous system | 3 months or more before pregnancy or1st trimester excluded | population based cohort retrospective | unexposed, sick | Adjustment: Yes |
1.22 [0.07;5.78] excluded (exposition period) |
1/683 31/21,549 | 32 | 683 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
S4074 R8636 |
Cooper, 2014 | Central nervous system defects | 1st trimester | retrospective cohort (claims database) | unexposed, sick | Adjustment: No | 3.07 [0.06;156.65] C | 0/56 0/171 | 0 | 56 |
|
ref | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total | 1 studies | 3.07 [0.06;156.65] | 0 | 56 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives |
Funnel plot not drawn. Less than 3 points.
Asymetry test p-value = NaN (by Egger's regression)
not enought points
Funnel plot not drawn. Less than 3 points.
excluded 3194, 4098